Nonetheless, the above studies provide strong evidence for presence of estrogen receptors in NSCLC and emphasize the importance of consistency in methodology, especially the use of validated antibodies and a consistent definition of positivity in future studies. This evidence concerns the gene ESR1 and non-small cell lung carcinoma.